Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pricing Debate

Set Alert for Pricing Debate

Six Questions For TB Alliance CEO On Pretomanid And Pricing Issues

TB Alliance CEO Mel Spigelman outlines to Scrip the contours of the non-profit’s commercialization deal with Mylan for pretomanid, which is part of an oral combination regimen, and maintains that the $1/day pricing ask for the drug is based on flawed assumptions and not currently feasible.

Commercial Strategy Pricing Debate

Latest From Pricing Debate

NGOs Urge Italian Govt Not To Replace Head Of Drugs Agency

The Italian health ministry is looking for someone to take over as director general of the medicines agency AIFA. The move has shocked health activists who see Luca Di Bassi as a champion of drug price transparency.

Italy Regulation

Importation, Pricing Policies Raised Concerns For US FDA's Project Orbis

Allowing multi-regulator collaboration on oncology application assessment may run into pricing issues if Canada and Australia gain access to novel drugs before European countries, US FDA's Pazdur says.

Pricing Debate Drug Review

Trump's International Pricing Proposal Being Revised To Adopt ‘Most Favored Nation’ Policy – Azar

HHS Secretary Alex Azar says that reshaping Administration’s upcoming proposed rule would drive Medicare Part B drug prices even lower than previously projected. As Part B drug costs are being blamed for higher premiums, the policy revisions are at OMB, but plan would reemerge as "a notice of proposed rulemaking if that comes out,” Azar said.

Pricing Debate Regulation

International Horizon Scanning Initiative To Level Pricing Playing Field

Nine countries are joining forces on horizon scanning with the aim of improving their chances of securing lower prices for high-cost drugs.

Europe International

Fair Pricing A Key Feature Of NHS England Drug Funding Proposals

Plans for a new commercial framework for publicly funded medicines in England are out for consultation. The concept of fair and responsible pricing figures large in the proposals.

Pricing Debate United Kingdom

White House Wants To Avoid Fight On Rebates, Get Quick Passage Of Senate Rx Pricing Bill

“We’re out of time for ideas," Domestic Policy Council Director Joe Grogan says. Trump administration is pushing hard to get the Senate drug pricing bill through Congress quickly and score a major victory for the President.

Pricing Debate Legislation

Rx Pricing, Rebating Should Be Back To Business As Usual In 2020, PBMs Say

Political focus of drug pricing debate has shifted away from pharmacy benefit managers, CVS Health’s Merlo suggests.

Pricing Debate Reimbursement

Drug Pricing Bill: Senate Sponsors ‘Not Backing Down’ From Inflation Rebates

Price inflation rebates are the linchpin of the legislation’s Democratic support, Sen. Chuck Grassley, R-IA, argues. But to many Republicans, they sound too much like price controls.

Pricing Debate Medicare

Everyone Wants A Piece Of The UK's NICE

Heath technology assessment body NICE says it has relaunched its international division to deal with the growing number of enquiries for advice it has been receiving from government agencies and organizations abroad.

United Kingdom International
See All
UsernamePublicRestriction

Register